fundvisualizer.com

Christopher Weil & Co Core InvestmentCWCFX

Performance (before sales charge)

As of 02/28/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2022
Stock
72.86%
Non-U.S. Stock
13.79%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
11.80%
Other
1.54%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2022

Basic materials

6.04%

Consumer cyclical

1.29%

Financial services

8.91%

Real estate

0.40%

Consumer defensive

2.01%

Health care

16.20%

Utilities

0.68%

Communication services

8.38%

Energy

0.00%

Industrials

12.29%

Technology

22.13%

Top 10 holdings

As of 12/31/2022

United Therapeutics Corp
13.00%
Cash *
6.16%
Berkshire Hathaway Inc Class B
5.44%
Box Inc Class A
4.92%
VanEck Gold Miners ETF
4.67%
Cleveland-Cliffs Inc
3.07%
ProShares Short S&P500
2.92%
Fluor Corp
2.53%
Alphabet Inc Class A
2.51%
Freeport-McMoRan Inc
2.29%
Fund assets

$89.19 Million

Share class

Other

Morningstar category

Large Blend

Expense ratio

1.13%

Investment objective

Growth

Documents